𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Better survival in female patients with hepatocellular carcinoma. Possible causes from a pathologic approach

✍ Scribed by Irene O. L. Ng; Matthew M. T. Ng; Edward C. S. Lai; Sheung T. Fan


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
475 KB
Volume
75
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Background. Hepatocellular carcinoma is notably more prevalent in men than in women.

Methods. To examine the sex-related characteristics of patients with primary hepatocellular carcinoma, 35 women were compared with 243 men, both groups having undergone surgical resection of the tumor.

Results. Women had a lower incidence of tumor recurrence, with median disease free survival of 19.5 months compared with 4.5 months for men (P < 0.001). Women also had more favorable actuarial survival than men [36.5 months for women compared with 12.4 months for men (P = 0.002)]. Women had a significantly higher incidence (80%) of tumor encapsulation than men (45%) ( P < 0.001). Furthermore, the tumors in women were frequently less invasive in terms of lower incidence of tumor microsatellites, liver invasion, and positive histologic margin. Tumor microsatellite formation was present with 16% of tumors in women, compared with 60% for men (P < 0.0001). Liver invasion was found in 37% of tumors in women and 61% in men (P = 0.03). Only 6% of tumors in women had a positive histologic margin, compared to 24% in men (P = 0.04). There was no statistical significance in the incidence of cirrhosis in'the nontumorous liver, hepatitis B surface antigen positivity, mean age, or tumor size, between women and men.

Conclusions. Women who had hepatocellular carcinoma and hepatic resection had better survival rates and a lower rate of tumor recurrence than male patients. The better prognosis in women with hepatocellular carcinoma appeared to be related to the pathobiologic characteristics of the tumor (i-e., frequent encapsulation and lower tumor invasiveness). Cancer 1995; 75:18-22.